Review



block randomisation and allocation of patients to treatment and control groups  (Klinge Pharma GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Klinge Pharma GmbH block randomisation and allocation of patients to treatment and control groups
    Block Randomisation And Allocation Of Patients To Treatment And Control Groups, supplied by Klinge Pharma GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/block+randomisation+and+allocation+of+patients+to+treatment+and+control+groups/block+randomisation+and+allocation+of+patients+to+treatment+and+control+groups/10__1002_slash_14651858__cd003230__pub4-652-21-27
    Average 90 stars, based on 1 article reviews
    block randomisation and allocation of patients to treatment and control groups - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Selection:

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Allocation concealment (selection bias) , Low risk , Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. The random code was stored in sealed envelopes.. .. Blinding (performance bias and detection bias) All outcomes , Low risk , Verum and placebo were indistinguishable in terms of outer appearance and taste.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Bias Authors’ judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. .. The random code was stored in sealed envelopes Blinding (performance bias and detection bias) All outcomes Low risk Verum and placebo were indistinguishable in terms of outer appearance and taste Incomplete outcome data (attrition bias) All outcomes Unclear risk It is unclear how incomplete outcome data were addressed Selective reporting (reporting bias) Low risk No evidence of selective reporting Other bias Unclear risk No evidence of other biases 25Horse chestnut seed extract for chronic venous insufficiency (Review) Copyright © 2012 The Cochrane Collaboration.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Risk of bias Bias Authors' judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. ..

    Blocking Assay:

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Allocation concealment (selection bias) , Low risk , Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. The random code was stored in sealed envelopes.. .. Blinding (performance bias and detection bias) All outcomes , Low risk , Verum and placebo were indistinguishable in terms of outer appearance and taste.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Bias Authors’ judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. .. The random code was stored in sealed envelopes Blinding (performance bias and detection bias) All outcomes Low risk Verum and placebo were indistinguishable in terms of outer appearance and taste Incomplete outcome data (attrition bias) All outcomes Unclear risk It is unclear how incomplete outcome data were addressed Selective reporting (reporting bias) Low risk No evidence of selective reporting Other bias Unclear risk No evidence of other biases 25Horse chestnut seed extract for chronic venous insufficiency (Review) Copyright © 2012 The Cochrane Collaboration.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Risk of bias Bias Authors' judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. ..

    Control:

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Allocation concealment (selection bias) , Low risk , Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. The random code was stored in sealed envelopes.. .. Blinding (performance bias and detection bias) All outcomes , Low risk , Verum and placebo were indistinguishable in terms of outer appearance and taste.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Bias Authors’ judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. .. The random code was stored in sealed envelopes Blinding (performance bias and detection bias) All outcomes Low risk Verum and placebo were indistinguishable in terms of outer appearance and taste Incomplete outcome data (attrition bias) All outcomes Unclear risk It is unclear how incomplete outcome data were addressed Selective reporting (reporting bias) Low risk No evidence of selective reporting Other bias Unclear risk No evidence of other biases 25Horse chestnut seed extract for chronic venous insufficiency (Review) Copyright © 2012 The Cochrane Collaboration.

    Article Title: Horse chestnut seed extract for chronic venous insufficiency
    Article Snippet: .. Risk of bias Bias Authors' judgement Support for judgement Allocation concealment (selection bias) Low risk Block randomisation and allocation of patients to treatment and control groups was performed centrally by Klinge Pharma. ..



    Similar Products

    90
    Klinge Pharma GmbH block randomisation and allocation of patients to treatment and control groups
    Block Randomisation And Allocation Of Patients To Treatment And Control Groups, supplied by Klinge Pharma GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/block+randomisation+and+allocation+of+patients+to+treatment+and+control+groups/block+randomisation+and+allocation+of+patients+to+treatment+and+control+groups/10__1002_slash_14651858__cd003230__pub4-652-21-27
    Average 90 stars, based on 1 article reviews
    block randomisation and allocation of patients to treatment and control groups - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results